Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Shares Outstanding (Diluted Average) (2016)

Historic Shares Outstanding (Diluted Average) for Amphastar Pharmaceuticals (AMPH) over the last 4 years, with Q2 2016 value amounting to $46.0 million.

  • Amphastar Pharmaceuticals' Shares Outstanding (Diluted Average) rose 249.5% to $46.0 million in Q2 2016 from the same period last year, while for Jun 2016 it was $46.0 million, marking a year-over-year increase of 249.5%. This contributed to the annual value of $45.0 million for FY2015, which is 715.97% up from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Shares Outstanding (Diluted Average) of $46.0 million as of Q2 2016, which was up 249.5% from $46.8 million recorded in Q1 2016.
  • Over the past 5 years, Amphastar Pharmaceuticals' Shares Outstanding (Diluted Average) peaked at $46.8 million during Q1 2016, and registered a low of $38769.0 during Q1 2014.
  • In the last 4 years, Amphastar Pharmaceuticals' Shares Outstanding (Diluted Average) had a median value of $38.9 million in 2013 and averaged $29.7 million.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Shares Outstanding (Diluted Average) crashed by 9989.76% in 2014 and then surged by 11494294.67% in 2015.
  • Over the past 4 years, Amphastar Pharmaceuticals' Shares Outstanding (Diluted Average) (Quarter) stood at $38.9 million in 2013, then grew by 7.91% to $42.0 million in 2014, then grew by 7.16% to $45.0 million in 2015, then grew by 2.24% to $46.0 million in 2016.
  • Its Shares Outstanding (Diluted Average) stands at $46.0 million for Q2 2016, versus $46.8 million for Q1 2016 and $45.0 million for Q4 2015.